The success of Sildenafil initially drove a period of growth for the drug industry, however recent changes present a complicated scenario for investors. Lower-cost alternatives are eroding profits, and continued patent https://murraydlar829462.pages10.com/the-blue-pill-and-pharma-a-precarious-play-76593422